Parathyroid hormone [PTH(1-34)] and parathyroid hormone-related protein [PTHrP(1-34)] promote reversion of hypertrophic chondrocytes to a prehypertrophic proliferating phenotype and prevent terminal differentiation of osteoblast-like cells

被引:72
|
作者
Zerega, B
Cermelli, S
Bianco, P
Cancedda, R
Cancedda, FD
机构
[1] Ist Nazl Ric Canc, Ctr Biotecnol Avanzate, I-16132 Genoa, Italy
[2] Univ Aquila, Dipartimento Med Sperimentale, I-67100 Laquila, Italy
[3] Univ Genoa, Dipartimento Oncol Biol & Genet, Genoa, Italy
[4] CNR, Ctr Studio Neurofisiol Cerebrale, Genoa, Italy
关键词
D O I
10.1359/jbmr.1999.14.8.1281
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effects of parathyroid hormone/parathyroid hormone-related protein (PTH/PTHrP) on late events in chondrocyte differentiation were investigated by a dual in vitro model where conditions of suspension versus adhesion culturing are permissive either for apoptosis or for the further differentiation of hypertrophic chondrocytes to osteoblast-like cells. Chick embryo hypertrophic chondrocytes maintained in suspension synthesized type II and type X collagen and organized their extracellular matrix, farming a tissue highly reminiscent of true cartilage, which eventually mineralized. The formation of mineralized cartilage was associated with the expression of alkaline phosphatase (ALP), arrest of cell growth, and apoptosis, as observed in growth plates in vivo. In this system, PTH/PTHrP was found to repress type X collagen synthesis, ALP expression, and cartilage matrix mineralization. Cell proliferation was resumed, whereas apoptosis was blocked. Hypertrophic chondrocytes cultured in adherent conditions in the presence of retinoic acid underwent further differentiation to osteoblast-like cells (i.e., they resumed cell proliferation, switched to type I collagen synthesis, and produced a mineralizing bone-like matrix). In this system, PTH addition to culture completely inhibited the expression of ALP and matrix mineralization, whereas cell proliferation and expression of type I collagen were not affected. These data indicate that PTH/PTHrP inhibit both the mineralization of a cartilage-like matrix and apoptosis (mimicked in the suspension culture) and the production of a mineralizing bone-like matrix, characterizing further differentiation of hypertrophic chondrocytes to osteoblasts like cells (mimicked in adhesion culture). Treatment of chondrocyte cultures with PTH/PTHrP reverts cultured cells in states of differentiation earlier than hypertrophic chondrocytes (suspension), or earlier than mineralizing osteoblast-like cells (adhesion). However, withdrawal of hormonal stimulation redirects cells toward their distinct, microenvironment-dependent, terminal differentiation and fate.
引用
收藏
页码:1281 / 1289
页数:9
相关论文
共 50 条
  • [31] Generalized-ensemble simulations of the human parathyroid hormone fragment PTH(1-34)
    Hansmann, UHE
    JOURNAL OF CHEMICAL PHYSICS, 2004, 120 (01): : 417 - 422
  • [32] Defining the entry point of parathyroid hormone (1-34) into the PTH1 receptor.
    Wittelsberger, A
    Corich, M
    Lee, B
    Thomas, BE
    Ahmad, A
    Chorev, M
    Mierke, DF
    Rosenblatt, M
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S477 - S477
  • [33] Position paper on the indications for the use of parathyroid hormone (PTH 1-34) in the treatment of osteoporosis
    Brown, S. L.
    JOURNAL OF ENDOCRINOLOGY METABOLISM AND DIABETES OF SOUTH AFRICA, 2009, 14 (01) : 61 - 62
  • [34] EFFECTS OF PARATHYROID-HORMONE AND A SYNTHETIC FRAGMENT (PTH 1-34) ON BONE INVITRO
    GAILLARD, PJ
    WASSENAAR, AM
    VANWIJHEWHEELER, ME
    PROCEEDINGS OF THE KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN SERIES C-BIOLOGICAL AND MEDICAL SCIENCES, 1977, 80 (04) : 267 - &
  • [35] Formulations for Intermittent Release of Parathyroid Hormone (1-34) and Local Enhancement of Osteoblast Activities
    Jeon, J. H.
    Puleo, D. A.
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2008, 13 (06) : 505 - 512
  • [36] Amino-terminal fragment (1-34) of parathyroid hormone-related protein inhibits migration and proliferation of cultured vascular smooth muscle cells
    Ishikawa, M
    Akishita, M
    Kozaki, K
    Toba, K
    Namiki, A
    Yamaguchi, T
    Orimo, H
    Ouchi, Y
    ATHEROSCLEROSIS, 1998, 136 (01) : 59 - 66
  • [37] C-terminal parathyroid hormone-related protein inhibits proliferation and differentiation of human osteoblast-like cells
    Martinez, ME
    GarciaOcana, A
    Sanchez, M
    Medina, S
    DelCampo, T
    Valin, A
    SanchezCabezudo, MJ
    Esbrit, P
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 (05) : 778 - 785
  • [38] THE SUPPRESSIVE EFFECT OF HUMAN PARATHYROID HORMONE-RELATED PROTEIN(1-34) ON ENDOTHELIN-1 PRODUCTION IN CULTURED ENDOTHELIAL-CELLS
    JIANG, BB
    MORIMOTO, S
    FUKUO, K
    TANIGUCHI, K
    CHEN, YH
    OGIHARA, T
    HYPERTENSION, 1992, 20 (03) : 434 - 434
  • [39] A Comparison of Parathyroid Hormone-Related Protein (1-36) and Parathyroid Hormone (1-34) on Markers of Bone Turnover and Bone Density in Postmenopausal Women: The PrOP Study
    Horwitz, Mara J.
    Augustine, Marilyn
    Kahn, Leila
    Martin, Emily
    Oakley, Christine C.
    Carneiro, Raquel M.
    Tedesco, Mary Beth
    Laslavic, Angela
    Sereika, Susan M.
    Bisello, Alessandro
    Garcia-Ocana, Adolfo
    Gundberg, Caren M.
    Cauley, Jane A.
    Stewart, Andrew F.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28 (11) : 2266 - 2276
  • [40] Parathyroid hormone-related peptide (1-34) reduces alveolar bone loss in type 1 diabetic rats
    Zhang, Wen
    Wu, Su-Zhen
    Zhou, Jian
    Chen, Hong-Min
    Gong, Ye -Li
    Peng, Fang-Fang
    Zhang, Bai-Fang
    ARCHIVES OF ORAL BIOLOGY, 2017, 83 : 13 - 19